MDSC-0602 NCT02784444


Laboratory : OCTETA

Study Name : 

Phase 2

Study Number : NCT02784444

Number of patients recruited : 200

Probability to be under placebo : 25%

Contacts : 

Contact: Dorothy Chang, MPH  657-251-2618

dorothy.chang@covance.com


Contact: Susan Wolfthal, MBA 508-350-0071

Susan.wolfthal@covance.com









Share on StockTwits

WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016